Direxion Daily Pharmaceutical & Medical Bull 3X Shares
Name
As of 11/25/2024Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
13.6%
1 yr return
58.6%
3 Yr Avg Return
-19.3%
5 Yr Avg Return
-12.5%
Net Assets
$15.4 M
Holdings in Top 10
53.0%
52 WEEK LOW AND HIGH
$9.1
$5.51
$10.33
Expenses
OPERATING FEES
Expense Ratio 1.53%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover N/A
Redemption Fee N/A
Min Investment
Standard (Taxable)
N/A
IRA
N/A
Fund Classification
Fund Type
Exchange Traded Fund
Name
As of 11/25/2024Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
PILL - Profile
Distributions
- YTD Total Return 13.6%
- 3 Yr Annualized Total Return -19.3%
- 5 Yr Annualized Total Return -12.5%
- Capital Gain Distribution Frequency N/A
- Net Income Ratio -0.39%
- Dividend Yield 1.3%
- Dividend Distribution Frequency Quarterly
Fund Details
-
Legal NameDirexion Daily Pharmaceutical & Medical Bull 3X Shares
-
Fund Family NameDirexion Shares ETF Trust
-
Inception DateNov 15, 2017
-
Shares Outstanding1300001
-
Share ClassN/A
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerPaul Brigandi
Fund Description
The Index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the Global Industry Classification Standard (GICS) pharmaceuticals sub-industry. To be eligible for inclusion in the Index, stocks must satisfy one of the following combined size and liquidity criteria: (1) have a float-adjusted market capitalization above $300 million with a float-adjusted liquidity ratio (defined by dollar value traded over the previous 12 months divided by the float-adjusted market capitalization as of the Index rebalancing reference date) above 50%; (2) have a float-adjusted market capitalization above $500 million with a float-adjusted liquidity ratio above 90%; or (3) have a float-adjusted market capitalization above $400 million with a float-adjusted liquidity ratio above 150%. The Index is rebalanced quarterly.As of December 29, 2023, the Index had 36 constituents with a median total market capitalization of $3 billion, total market capitalizations ranging from $559.7 million to $553.4 billion and were concentrated in the pharmaceuticals industry, which is included in the healthcare sector.The components of the Index and the percentages represented by various sectors in the Index may change over time. The Fund will concentrate its investment in a particular industry or group of industries (i.e., hold 25% or more of its total assets in the stocks of a particular industry or group of industries) to approximately the same extent as the Index is so concentrated.The Fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments, such as swap agreements, securities of the Index, and exchange-traded funds ("ETFs") that track the Index, that, in combination, provide 3X daily leveraged exposure to the Index, consistent with the Fund's investment objective. The financial instruments in which the Fund most commonly invests are swap agreements and futures agreements which are intended to produce economically leveraged investment results.The Fund may invest in the securities of the Index, a representative sample of the securities in the Index that has aggregate characteristics similar to those of the Index, an ETF that tracks the Index or a substantially similar index, and may utilize derivatives, such as swaps or futures on the Index or on an ETF that tracks the same Index or a substantially similar index, that provide leveraged exposure to the above.The Fund seeks to remain fully invested at all times, consistent with its stated investment objective, but may not always have investment exposure to all of the securities in the Index, or its weighting of investment exposure to securities or industries may be different from that of the Index. In addition, the Fund may invest directly or indirectly in securities not included in the Index. In all cases, the investments would be designed to help the Fund track the Index.The Fund will attempt to achieve its investment objective without regard to overall market movement or the increase or decrease of the value of the securities in the Index. At the close of the markets each trading day, Rafferty rebalances the Fund’s portfolio so that its exposure to the Index is consistent with the Fund’s investment objective. The impact of the Index’s movements during the day will affect whether the Fund’s portfolio needs to be re-positioned. For example, if the Index has risen on a given day, net assets of the Fund should rise, meaning that the Fund’s exposure will need to be increased. Conversely, if the Index has fallen on a given day, net assets of the Fund should fall, meaning the Fund’s exposure will need to be reduced. This re-positioning strategy typically results in high portfolio turnover. On a day-to-day basis, the Fund is expected to hold ETFs and money market funds, deposit accounts with institutions with high quality credit ratings (i.e. investment grade or higher), and/or short-term debt instruments that have terms-to-maturity of less than 397 days and exhibit high quality credit profiles, including U.S. government securities and repurchase agreements. The Fund may lend securities representing up to one-third of the value of the Fund’s total assets (excluding the value of the collateral received).The terms “daily,” “day,” and “trading day,” refer to the period from the close of the markets on one trading day to the close of the markets on the next trading day. The Fund is “non-diversified,” meaning that a relatively high percentage of its assets may be invested in a limited number of issuers of securities. Additionally, the Fund’s investment objective is not a fundamental policy and may be changed by the Fund’s Board of Trustees without shareholder approval.Because of daily rebalancing and the compounding of each day’s return over time, the return of the Fund for periods longer than a single day will be the result of each day’s returns compounded over the period, which will very likely differ from 300% of the return of the Index over the same period. The Fund will lose money if the Index performance is flat over time, and as a result of daily rebalancing, the Index’s volatility and the effects of compounding, it is even possible that the Fund will lose money over time while the Index’s performance increases over a period longer than a single day.
Read More
PILL - Performance
Return Ranking - Trailing
| Period | PILL Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 13.6% | -68.8% | 130.1% | 73.42% |
| 1 Yr | 58.6% | -59.2% | 178.2% | 31.01% |
| 3 Yr | -19.3%* | -48.3% | 36.6% | 91.77% |
| 5 Yr | -12.5%* | -40.6% | 55.4% | 91.14% |
| 10 Yr | N/A* | -37.7% | 41.9% | 77.27% |
* Annualized
Return Ranking - Calendar
| Period | PILL Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2023 | -13.6% | -56.9% | 257.9% | 91.77% |
| 2022 | -43.5% | -91.0% | 124.5% | 58.23% |
| 2021 | -37.3% | -79.4% | 168.2% | 94.94% |
| 2020 | 0.3% | -97.4% | 132.6% | 65.19% |
| 2019 | 18.7% | -53.1% | 229.8% | 92.31% |
Total Return Ranking - Trailing
| Period | PILL Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 13.6% | -68.8% | 130.1% | 73.42% |
| 1 Yr | 58.6% | -59.2% | 178.2% | 31.01% |
| 3 Yr | -19.3%* | -48.3% | 36.6% | 91.77% |
| 5 Yr | -12.5%* | -40.6% | 55.4% | 91.14% |
| 10 Yr | N/A* | -37.7% | 41.9% | N/A |
* Annualized
Total Return Ranking - Calendar
| Period | PILL Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2023 | -12.1% | -55.8% | 259.6% | 91.14% |
| 2022 | -43.2% | -91.0% | 130.7% | 61.39% |
| 2021 | -37.3% | -79.4% | 168.2% | 94.94% |
| 2020 | 0.3% | -97.4% | 132.6% | 67.72% |
| 2019 | 19.3% | -52.7% | 231.9% | 93.59% |
PILL - Holdings
Concentration Analysis
| PILL | Category Low | Category High | PILL % Rank | |
|---|---|---|---|---|
| Net Assets | 15.4 M | 1.5 M | 22.2 B | 75.45% |
| Number of Holdings | 49 | 5 | 2009 | 57.41% |
| Net Assets in Top 10 | 9.12 M | 1.08 M | 9.23 B | 71.60% |
| Weighting of Top 10 | 52.95% | 13.9% | 185.3% | 61.73% |
Top 10 Holdings
- DREYFUS GOV'T CASH MGMT -INSTITUTIONAL CUSIP 262006208 DGCXX (#289) 17.02%
- GOLDMAN SACHS FIN GOV 465 INSTITUT 8.42%
- SP PHARMACEUTICALS SELECT INDEX SWAP 5.50%
- GOLDMAN FINL SQ TRSRY INST 506 3.94%
- SP PHARMACEUTICALS SELECT INDEX SWAP 3.10%
- Axsome Therapeutics Incorporation COM USD0.0001 3.06%
- Viatris Inc COM 3.06%
- Intra-Cellular Therapies Inc USD0.0001 3.00%
- Bristol-Myers Squibb Company COM USD0.10 2.98%
- Pfizer Inc. COM USD0.05 2.87%
Asset Allocation
| Weighting | Return Low | Return High | PILL % Rank | |
|---|---|---|---|---|
| Stocks | 71.84% | 0.00% | 375.12% | 48.15% |
| Cash | 29.37% | 0.00% | 104.72% | 19.14% |
| Other | 10.84% | -7.39% | 99.69% | 75.31% |
| Preferred Stocks | 0.00% | 0.00% | 1.99% | 74.07% |
| Convertible Bonds | 0.00% | 0.00% | 0.32% | 76.54% |
| Bonds | 0.00% | 0.00% | 37.59% | 78.40% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | PILL % Rank | |
|---|---|---|---|---|
| Healthcare | 100.00% | 0.00% | 100.00% | 3.20% |
| Utilities | 0.00% | 0.00% | 100.00% | 82.40% |
| Technology | 0.00% | 0.00% | 100.00% | 89.60% |
| Real Estate | 0.00% | 0.00% | 100.00% | 83.20% |
| Industrials | 0.00% | 0.00% | 100.00% | 91.20% |
| Financial Services | 0.00% | 0.00% | 100.00% | 88.80% |
| Energy | 0.00% | 0.00% | 100.00% | 87.20% |
| Communication Services | 0.00% | 0.00% | 100.00% | 88.80% |
| Consumer Defense | 0.00% | 0.00% | 52.46% | 88.00% |
| Consumer Cyclical | 0.00% | 0.00% | 94.15% | 90.40% |
| Basic Materials | 0.00% | 0.00% | 100.00% | 89.60% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | PILL % Rank | |
|---|---|---|---|---|
| US | 71.84% | 0.00% | 375.12% | 48.15% |
| Non US | 0.00% | 0.00% | 20.00% | 74.07% |
PILL - Expenses
Operational Fees
| PILL Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 1.53% | 0.68% | 5.63% | 63.29% |
| Management Fee | 0.75% | 0.00% | 0.95% | 59.28% |
| 12b-1 Fee | 0.00% | 0.00% | 1.00% | 31.50% |
| Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
| PILL Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 4.75% | 4.75% | N/A |
| Deferred Load | N/A | 1.00% | 1.00% | N/A |
Trading Fees
| PILL Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | N/A | N/A | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| PILL Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | N/A | 0.00% | 266.00% | 52.17% |
PILL - Distributions
Dividend Yield Analysis
| PILL | Category Low | Category High | PILL % Rank | |
|---|---|---|---|---|
| Dividend Yield | 1.32% | 0.00% | 18.26% | 17.96% |
Dividend Distribution Analysis
| PILL | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Quarterly | Annually | Monthly | Annual |
Net Income Ratio Analysis
| PILL | Category Low | Category High | PILL % Rank | |
|---|---|---|---|---|
| Net Income Ratio | -0.39% | -2.77% | 2.92% | 39.24% |
Capital Gain Distribution Analysis
| PILL | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually | Annually | Annually |
Distributions History
| Date | Amount | Type |
|---|---|---|
| Sep 24, 2024 | $0.029 | OrdinaryDividend |
| Jun 25, 2024 | $0.022 | OrdinaryDividend |
| Mar 19, 2024 | $0.027 | OrdinaryDividend |
| Dec 21, 2023 | $0.038 | OrdinaryDividend |
| Sep 19, 2023 | $0.035 | OrdinaryDividend |
| Jun 21, 2023 | $0.049 | OrdinaryDividend |
| Mar 21, 2023 | $0.019 | OrdinaryDividend |
| Dec 20, 2022 | $0.032 | OrdinaryDividend |
| Sep 20, 2022 | $0.017 | OrdinaryDividend |
| Jun 22, 2022 | $0.004 | OrdinaryDividend |
| Mar 22, 2022 | $0.008 | OrdinaryDividend |
| Dec 21, 2021 | $0.000 | OrdinaryDividend |
| Dec 23, 2019 | $0.000 | OrdinaryDividend |
| Sep 24, 2019 | $0.014 | OrdinaryDividend |
| Jun 25, 2019 | $0.022 | OrdinaryDividend |
| Mar 19, 2019 | $0.057 | OrdinaryDividend |
| Dec 27, 2018 | $0.099 | OrdinaryDividend |
| Sep 25, 2018 | $0.043 | OrdinaryDividend |
| Jun 19, 2018 | $0.052 | OrdinaryDividend |
| Dec 19, 2017 | $0.014 | OrdinaryDividend |
PILL - Fund Manager Analysis
Managers
Paul Brigandi
Start Date
Tenure
Tenure Rank
Nov 15, 2017
4.54
4.5%
Paul Brigandi, the Fund’s Portfolio Manager, is primarily responsible for the day-to-day management of the Fund. An investment trading team of Rafferty employees assists Mr. Brigandi in the day-to-day management of the Fund subject to his primary responsibility and oversight. The Portfolio Manager works with the investment trading team to decide the target allocation of the Fund’s investments and on a day-to-day basis, an individual portfolio trader executes transactions for the Fund consistent with its target allocation. The members of the investment trading team rotate among the various series of the Trust, including the Fund periodically so that no single individual is assigned to a specific Fund for extended periods of time. Mr. Brigandi has been a Portfolio Manager at Rafferty since June 2004. Mr. Brigandi was previously involved in the equity trading training program for Fleet Boston Financial Corporation from August 2002 to April 2004. Mr. Brigandi is a 2002 graduate of Fordham University.
Tony Ng
Start Date
Tenure
Tenure Rank
Nov 15, 2017
4.54
4.5%
Tony Ng is a Portfolio Manager and joined Rafferty Asset Management in April 2006. He was previously a Team Leader in the Trading Assistant Group with Goldman Sachs from 2004 to 2006. Hg was employed with Deutsche Asset Management from 1998 to 2004. Mr. Ng graduated from State University at Buffalo in 1998.
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 1.79 | 28.9 | 9.84 | 8.67 |